ATAI Life Sciences N.V. (NASDAQ: ATAI) Stock Information | RedChip

ATAI Life Sciences N.V. (NASDAQ: ATAI)


$1.2350
+0.0450 ( +3.78% ) 756.7K

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Market Data


Open


$1.2350

Previous close


$1.1900

Volume


756.7K

Market cap


$197.17M

Day range


$1.1550 - $1.2350

52 week range


$1.0300 - $2.8500

SEC Filings


Form Type Description Pages Date
pre Proxies and info statements 4 Apr 12, 2024
4 Insider transactions 1 Apr 04, 2024
4 Insider transactions 1 Apr 04, 2024
4 Insider transactions 1 Apr 04, 2024
8-k 8K-related 15 Mar 28, 2024
10-k Annual reports 120 Mar 28, 2024
4 Insider transactions 1 Mar 15, 2024
4 Insider transactions 1 Mar 15, 2024
4 Insider transactions 1 Mar 15, 2024
4 Insider transactions 1 Mar 15, 2024

Latest News